US 12415843
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer
granted A61KA61K2039/505A61K2239/48
Quick answer
US patent 12415843 (Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer) held by The Regents of the University of California expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2239/48, A61K38/21, A61K38/212